Global OTC Anti-Infective Products Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global High Pressure Processing (HPP) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
High-Pressure Processing (HPP) is a cutting-edge USDA–approved all natural process that utilizes intense water pressure to protect against harmful bacteria without affecting a food product’s taste, texture, appearance or nutritional value. Products are packaged, sealed and then placed in a cylinder-shaped pressure chamber where it is surrounded by water. Up to 87,000 pounds of water pressure—roughly equal to five to six times the pressure found at the bottom of the deepest ocean—are exerted per square inch, protecting against harmful bacteria and sealing in freshness and flavor naturally, with no preservatives needed. HPP is one of the latest technologies that utilize non-heat methods to preserve food. It has been studied by scientists for more than a hundred years, but only within the past 20 years have companies started applying HPP commercially. In this report, we study the market size of food, which use high pressure processing. Some company, which offer High Pressure Processing (HPP) to the food manufacturing industry, is not covered in our report.
In the United States, key players of high pressure processing (HPP) include Hormel Food, Calavo Growers, Cargill, Wholly Guacamole, etc. Top five manufacturers hold a share over 35%. In terms of product, juices and beverages is the largest segment, with a share over 35%. And in terms of application, the largest application is supermarket, with a share over 60%.
LP Information, Inc. (LPI) ' newest research report, the “High Pressure Processing (HPP) Industry Forecast” looks at past sales and reviews total world High Pressure Processing (HPP) sales in 2024, providing a comprehensive analysis by region and market sector of projected High Pressure Processing (HPP) sales for 2025 through 2031. With High Pressure Processing (HPP) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world High Pressure Processing (HPP) industry.
This Insight Report provides a comprehensive analysis of the global High Pressure Processing (HPP) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on High Pressure Processing (HPP) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global High Pressure Processing (HPP) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for High Pressure Processing (HPP) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global High Pressure Processing (HPP).
This report presents a comprehensive overview, market shares, and growth opportunities of High Pressure Processing (HPP) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global High Pressure Processing (HPP) market?
What factors are driving High Pressure Processing (HPP) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do High Pressure Processing (HPP) market opportunities vary by end market size?
How does High Pressure Processing (HPP) break out by Type, by Application?
The global High Pressure Processing (HPP) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
High-Pressure Processing (HPP) is a cutting-edge USDA–approved all natural process that utilizes intense water pressure to protect against harmful bacteria without affecting a food product’s taste, texture, appearance or nutritional value. Products are packaged, sealed and then placed in a cylinder-shaped pressure chamber where it is surrounded by water. Up to 87,000 pounds of water pressure—roughly equal to five to six times the pressure found at the bottom of the deepest ocean—are exerted per square inch, protecting against harmful bacteria and sealing in freshness and flavor naturally, with no preservatives needed. HPP is one of the latest technologies that utilize non-heat methods to preserve food. It has been studied by scientists for more than a hundred years, but only within the past 20 years have companies started applying HPP commercially. In this report, we study the market size of food, which use high pressure processing. Some company, which offer High Pressure Processing (HPP) to the food manufacturing industry, is not covered in our report.
In the United States, key players of high pressure processing (HPP) include Hormel Food, Calavo Growers, Cargill, Wholly Guacamole, etc. Top five manufacturers hold a share over 35%. In terms of product, juices and beverages is the largest segment, with a share over 35%. And in terms of application, the largest application is supermarket, with a share over 60%.
LP Information, Inc. (LPI) ' newest research report, the “High Pressure Processing (HPP) Industry Forecast” looks at past sales and reviews total world High Pressure Processing (HPP) sales in 2024, providing a comprehensive analysis by region and market sector of projected High Pressure Processing (HPP) sales for 2025 through 2031. With High Pressure Processing (HPP) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world High Pressure Processing (HPP) industry.
This Insight Report provides a comprehensive analysis of the global High Pressure Processing (HPP) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on High Pressure Processing (HPP) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global High Pressure Processing (HPP) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for High Pressure Processing (HPP) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global High Pressure Processing (HPP).
This report presents a comprehensive overview, market shares, and growth opportunities of High Pressure Processing (HPP) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Meat and Poultry Products
- Juices and Beverages
- Fruit and Vegetable
- Seafood Products
- Others
- Supermarket
- Direct Store
- Online
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hormel Food
- Calavo Growers
- Cargill
- Wholly Guacamole
- Good Foods
- Perdue Farms
- Suja Life
- Evolution Fresh
- Clearwater Seafoods
- Motivatit
What is the 10-year outlook for the global High Pressure Processing (HPP) market?
What factors are driving High Pressure Processing (HPP) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do High Pressure Processing (HPP) market opportunities vary by end market size?
How does High Pressure Processing (HPP) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global OTC Anti-Infective Products Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for OTC Anti-Infective Products by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for OTC Anti-Infective Products by Country/Region, 2020, 2024 & 2031
2.2 OTC Anti-Infective Products Segment by Type
2.2.1 Antifungal
2.2.2 Antibacterial
2.2.3 Antiviral
2.2.4 Antiseptics
2.2.5 Others
2.3 OTC Anti-Infective Products Sales by Type
2.3.1 Global OTC Anti-Infective Products Sales Market Share by Type (2020-2025)
2.3.2 Global OTC Anti-Infective Products Revenue and Market Share by Type (2020-2025)
2.3.3 Global OTC Anti-Infective Products Sale Price by Type (2020-2025)
2.4 OTC Anti-Infective Products Segment by Sales Channel
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 OTC Anti-Infective Products Sales by Sales Channel
2.5.1 Global OTC Anti-Infective Products Sale Market Share by Sales Channel (2020-2025)
2.5.2 Global OTC Anti-Infective Products Revenue and Market Share by Sales Channel (2020-2025)
2.5.3 Global OTC Anti-Infective Products Sale Price by Sales Channel (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global OTC Anti-Infective Products Breakdown Data by Company
3.1.1 Global OTC Anti-Infective Products Annual Sales by Company (2020-2025)
3.1.2 Global OTC Anti-Infective Products Sales Market Share by Company (2020-2025)
3.2 Global OTC Anti-Infective Products Annual Revenue by Company (2020-2025)
3.2.1 Global OTC Anti-Infective Products Revenue by Company (2020-2025)
3.2.2 Global OTC Anti-Infective Products Revenue Market Share by Company (2020-2025)
3.3 Global OTC Anti-Infective Products Sale Price by Company
3.4 Key Manufacturers OTC Anti-Infective Products Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers OTC Anti-Infective Products Product Location Distribution
3.4.2 Players OTC Anti-Infective Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OTC ANTI-INFECTIVE PRODUCTS BY GEOGRAPHIC REGION
4.1 World Historic OTC Anti-Infective Products Market Size by Geographic Region (2020-2025)
4.1.1 Global OTC Anti-Infective Products Annual Sales by Geographic Region (2020-2025)
4.1.2 Global OTC Anti-Infective Products Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic OTC Anti-Infective Products Market Size by Country/Region (2020-2025)
4.2.1 Global OTC Anti-Infective Products Annual Sales by Country/Region (2020-2025)
4.2.2 Global OTC Anti-Infective Products Annual Revenue by Country/Region (2020-2025)
4.3 Americas OTC Anti-Infective Products Sales Growth
4.4 APAC OTC Anti-Infective Products Sales Growth
4.5 Europe OTC Anti-Infective Products Sales Growth
4.6 Middle East & Africa OTC Anti-Infective Products Sales Growth
5 AMERICAS
5.1 Americas OTC Anti-Infective Products Sales by Country
5.1.1 Americas OTC Anti-Infective Products Sales by Country (2020-2025)
5.1.2 Americas OTC Anti-Infective Products Revenue by Country (2020-2025)
5.2 Americas OTC Anti-Infective Products Sales by Type (2020-2025)
5.3 Americas OTC Anti-Infective Products Sales by Sales Channel (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC OTC Anti-Infective Products Sales by Region
6.1.1 APAC OTC Anti-Infective Products Sales by Region (2020-2025)
6.1.2 APAC OTC Anti-Infective Products Revenue by Region (2020-2025)
6.2 APAC OTC Anti-Infective Products Sales by Type (2020-2025)
6.3 APAC OTC Anti-Infective Products Sales by Sales Channel (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe OTC Anti-Infective Products by Country
7.1.1 Europe OTC Anti-Infective Products Sales by Country (2020-2025)
7.1.2 Europe OTC Anti-Infective Products Revenue by Country (2020-2025)
7.2 Europe OTC Anti-Infective Products Sales by Type (2020-2025)
7.3 Europe OTC Anti-Infective Products Sales by Sales Channel (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa OTC Anti-Infective Products by Country
8.1.1 Middle East & Africa OTC Anti-Infective Products Sales by Country (2020-2025)
8.1.2 Middle East & Africa OTC Anti-Infective Products Revenue by Country (2020-2025)
8.2 Middle East & Africa OTC Anti-Infective Products Sales by Type (2020-2025)
8.3 Middle East & Africa OTC Anti-Infective Products Sales by Sales Channel (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of OTC Anti-Infective Products
10.3 Manufacturing Process Analysis of OTC Anti-Infective Products
10.4 Industry Chain Structure of OTC Anti-Infective Products
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 OTC Anti-Infective Products Distributors
11.3 OTC Anti-Infective Products Customer
12 WORLD FORECAST REVIEW FOR OTC ANTI-INFECTIVE PRODUCTS BY GEOGRAPHIC REGION
12.1 Global OTC Anti-Infective Products Market Size Forecast by Region
12.1.1 Global OTC Anti-Infective Products Forecast by Region (2026-2031)
12.1.2 Global OTC Anti-Infective Products Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global OTC Anti-Infective Products Forecast by Type (2026-2031)
12.7 Global OTC Anti-Infective Products Forecast by Sales Channel (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer OTC Anti-Infective Products Product Portfolios and Specifications
13.1.3 Bayer OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK OTC Anti-Infective Products Product Portfolios and Specifications
13.2.3 GSK OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva OTC Anti-Infective Products Product Portfolios and Specifications
13.3.3 Teva OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson OTC Anti-Infective Products Product Portfolios and Specifications
13.4.3 Johnson & Johnson OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 NOVARTIS
13.5.1 NOVARTIS Company Information
13.5.2 NOVARTIS OTC Anti-Infective Products Product Portfolios and Specifications
13.5.3 NOVARTIS OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 NOVARTIS Main Business Overview
13.5.5 NOVARTIS Latest Developments
13.6 MYLAN
13.6.1 MYLAN Company Information
13.6.2 MYLAN OTC Anti-Infective Products Product Portfolios and Specifications
13.6.3 MYLAN OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 MYLAN Main Business Overview
13.6.5 MYLAN Latest Developments
13.7 Sun Pharma
13.7.1 Sun Pharma Company Information
13.7.2 Sun Pharma OTC Anti-Infective Products Product Portfolios and Specifications
13.7.3 Sun Pharma OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sun Pharma Main Business Overview
13.7.5 Sun Pharma Latest Developments
13.8 CR SANJIU
13.8.1 CR SANJIU Company Information
13.8.2 CR SANJIU OTC Anti-Infective Products Product Portfolios and Specifications
13.8.3 CR SANJIU OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 CR SANJIU Main Business Overview
13.8.5 CR SANJIU Latest Developments
13.9 Cipla
13.9.1 Cipla Company Information
13.9.2 Cipla OTC Anti-Infective Products Product Portfolios and Specifications
13.9.3 Cipla OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Cipla Main Business Overview
13.9.5 Cipla Latest Developments
13.10 Lingrui
13.10.1 Lingrui Company Information
13.10.2 Lingrui OTC Anti-Infective Products Product Portfolios and Specifications
13.10.3 Lingrui OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Lingrui Main Business Overview
13.10.5 Lingrui Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global OTC Anti-Infective Products Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for OTC Anti-Infective Products by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for OTC Anti-Infective Products by Country/Region, 2020, 2024 & 2031
2.2 OTC Anti-Infective Products Segment by Type
2.2.1 Antifungal
2.2.2 Antibacterial
2.2.3 Antiviral
2.2.4 Antiseptics
2.2.5 Others
2.3 OTC Anti-Infective Products Sales by Type
2.3.1 Global OTC Anti-Infective Products Sales Market Share by Type (2020-2025)
2.3.2 Global OTC Anti-Infective Products Revenue and Market Share by Type (2020-2025)
2.3.3 Global OTC Anti-Infective Products Sale Price by Type (2020-2025)
2.4 OTC Anti-Infective Products Segment by Sales Channel
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 OTC Anti-Infective Products Sales by Sales Channel
2.5.1 Global OTC Anti-Infective Products Sale Market Share by Sales Channel (2020-2025)
2.5.2 Global OTC Anti-Infective Products Revenue and Market Share by Sales Channel (2020-2025)
2.5.3 Global OTC Anti-Infective Products Sale Price by Sales Channel (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global OTC Anti-Infective Products Breakdown Data by Company
3.1.1 Global OTC Anti-Infective Products Annual Sales by Company (2020-2025)
3.1.2 Global OTC Anti-Infective Products Sales Market Share by Company (2020-2025)
3.2 Global OTC Anti-Infective Products Annual Revenue by Company (2020-2025)
3.2.1 Global OTC Anti-Infective Products Revenue by Company (2020-2025)
3.2.2 Global OTC Anti-Infective Products Revenue Market Share by Company (2020-2025)
3.3 Global OTC Anti-Infective Products Sale Price by Company
3.4 Key Manufacturers OTC Anti-Infective Products Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers OTC Anti-Infective Products Product Location Distribution
3.4.2 Players OTC Anti-Infective Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OTC ANTI-INFECTIVE PRODUCTS BY GEOGRAPHIC REGION
4.1 World Historic OTC Anti-Infective Products Market Size by Geographic Region (2020-2025)
4.1.1 Global OTC Anti-Infective Products Annual Sales by Geographic Region (2020-2025)
4.1.2 Global OTC Anti-Infective Products Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic OTC Anti-Infective Products Market Size by Country/Region (2020-2025)
4.2.1 Global OTC Anti-Infective Products Annual Sales by Country/Region (2020-2025)
4.2.2 Global OTC Anti-Infective Products Annual Revenue by Country/Region (2020-2025)
4.3 Americas OTC Anti-Infective Products Sales Growth
4.4 APAC OTC Anti-Infective Products Sales Growth
4.5 Europe OTC Anti-Infective Products Sales Growth
4.6 Middle East & Africa OTC Anti-Infective Products Sales Growth
5 AMERICAS
5.1 Americas OTC Anti-Infective Products Sales by Country
5.1.1 Americas OTC Anti-Infective Products Sales by Country (2020-2025)
5.1.2 Americas OTC Anti-Infective Products Revenue by Country (2020-2025)
5.2 Americas OTC Anti-Infective Products Sales by Type (2020-2025)
5.3 Americas OTC Anti-Infective Products Sales by Sales Channel (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC OTC Anti-Infective Products Sales by Region
6.1.1 APAC OTC Anti-Infective Products Sales by Region (2020-2025)
6.1.2 APAC OTC Anti-Infective Products Revenue by Region (2020-2025)
6.2 APAC OTC Anti-Infective Products Sales by Type (2020-2025)
6.3 APAC OTC Anti-Infective Products Sales by Sales Channel (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe OTC Anti-Infective Products by Country
7.1.1 Europe OTC Anti-Infective Products Sales by Country (2020-2025)
7.1.2 Europe OTC Anti-Infective Products Revenue by Country (2020-2025)
7.2 Europe OTC Anti-Infective Products Sales by Type (2020-2025)
7.3 Europe OTC Anti-Infective Products Sales by Sales Channel (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa OTC Anti-Infective Products by Country
8.1.1 Middle East & Africa OTC Anti-Infective Products Sales by Country (2020-2025)
8.1.2 Middle East & Africa OTC Anti-Infective Products Revenue by Country (2020-2025)
8.2 Middle East & Africa OTC Anti-Infective Products Sales by Type (2020-2025)
8.3 Middle East & Africa OTC Anti-Infective Products Sales by Sales Channel (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of OTC Anti-Infective Products
10.3 Manufacturing Process Analysis of OTC Anti-Infective Products
10.4 Industry Chain Structure of OTC Anti-Infective Products
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 OTC Anti-Infective Products Distributors
11.3 OTC Anti-Infective Products Customer
12 WORLD FORECAST REVIEW FOR OTC ANTI-INFECTIVE PRODUCTS BY GEOGRAPHIC REGION
12.1 Global OTC Anti-Infective Products Market Size Forecast by Region
12.1.1 Global OTC Anti-Infective Products Forecast by Region (2026-2031)
12.1.2 Global OTC Anti-Infective Products Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global OTC Anti-Infective Products Forecast by Type (2026-2031)
12.7 Global OTC Anti-Infective Products Forecast by Sales Channel (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer OTC Anti-Infective Products Product Portfolios and Specifications
13.1.3 Bayer OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK OTC Anti-Infective Products Product Portfolios and Specifications
13.2.3 GSK OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva OTC Anti-Infective Products Product Portfolios and Specifications
13.3.3 Teva OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson OTC Anti-Infective Products Product Portfolios and Specifications
13.4.3 Johnson & Johnson OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 NOVARTIS
13.5.1 NOVARTIS Company Information
13.5.2 NOVARTIS OTC Anti-Infective Products Product Portfolios and Specifications
13.5.3 NOVARTIS OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 NOVARTIS Main Business Overview
13.5.5 NOVARTIS Latest Developments
13.6 MYLAN
13.6.1 MYLAN Company Information
13.6.2 MYLAN OTC Anti-Infective Products Product Portfolios and Specifications
13.6.3 MYLAN OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 MYLAN Main Business Overview
13.6.5 MYLAN Latest Developments
13.7 Sun Pharma
13.7.1 Sun Pharma Company Information
13.7.2 Sun Pharma OTC Anti-Infective Products Product Portfolios and Specifications
13.7.3 Sun Pharma OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sun Pharma Main Business Overview
13.7.5 Sun Pharma Latest Developments
13.8 CR SANJIU
13.8.1 CR SANJIU Company Information
13.8.2 CR SANJIU OTC Anti-Infective Products Product Portfolios and Specifications
13.8.3 CR SANJIU OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 CR SANJIU Main Business Overview
13.8.5 CR SANJIU Latest Developments
13.9 Cipla
13.9.1 Cipla Company Information
13.9.2 Cipla OTC Anti-Infective Products Product Portfolios and Specifications
13.9.3 Cipla OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Cipla Main Business Overview
13.9.5 Cipla Latest Developments
13.10 Lingrui
13.10.1 Lingrui Company Information
13.10.2 Lingrui OTC Anti-Infective Products Product Portfolios and Specifications
13.10.3 Lingrui OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Lingrui Main Business Overview
13.10.5 Lingrui Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. OTC Anti-Infective Products Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. OTC Anti-Infective Products Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Antifungal
Table 4. Major Players of Antibacterial
Table 5. Major Players of Antiviral
Table 6. Major Players of Antiseptics
Table 7. Major Players of Others
Table 8. Global OTC Anti-Infective Products Sales by Type (2020-2025) & (M Units)
Table 9. Global OTC Anti-Infective Products Sales Market Share by Type (2020-2025)
Table 10. Global OTC Anti-Infective Products Revenue by Type (2020-2025) & ($ million)
Table 11. Global OTC Anti-Infective Products Revenue Market Share by Type (2020-2025)
Table 12. Global OTC Anti-Infective Products Sale Price by Type (2020-2025) & (US$/Unit)
Table 13. Global OTC Anti-Infective Products Sale by Sales Channel (2020-2025) & (M Units)
Table 14. Global OTC Anti-Infective Products Sale Market Share by Sales Channel (2020-2025)
Table 15. Global OTC Anti-Infective Products Revenue by Sales Channel (2020-2025) & ($ million)
Table 16. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2020-2025)
Table 17. Global OTC Anti-Infective Products Sale Price by Sales Channel (2020-2025) & (US$/Unit)
Table 18. Global OTC Anti-Infective Products Sales by Company (2020-2025) & (M Units)
Table 19. Global OTC Anti-Infective Products Sales Market Share by Company (2020-2025)
Table 20. Global OTC Anti-Infective Products Revenue by Company (2020-2025) & ($ millions)
Table 21. Global OTC Anti-Infective Products Revenue Market Share by Company (2020-2025)
Table 22. Global OTC Anti-Infective Products Sale Price by Company (2020-2025) & (US$/Unit)
Table 23. Key Manufacturers OTC Anti-Infective Products Producing Area Distribution and Sales Area
Table 24. Players OTC Anti-Infective Products Products Offered
Table 25. OTC Anti-Infective Products Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global OTC Anti-Infective Products Sales by Geographic Region (2020-2025) & (M Units)
Table 29. Global OTC Anti-Infective Products Sales Market Share Geographic Region (2020-2025)
Table 30. Global OTC Anti-Infective Products Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global OTC Anti-Infective Products Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global OTC Anti-Infective Products Sales by Country/Region (2020-2025) & (M Units)
Table 33. Global OTC Anti-Infective Products Sales Market Share by Country/Region (2020-2025)
Table 34. Global OTC Anti-Infective Products Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global OTC Anti-Infective Products Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas OTC Anti-Infective Products Sales by Country (2020-2025) & (M Units)
Table 37. Americas OTC Anti-Infective Products Sales Market Share by Country (2020-2025)
Table 38. Americas OTC Anti-Infective Products Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas OTC Anti-Infective Products Sales by Type (2020-2025) & (M Units)
Table 40. Americas OTC Anti-Infective Products Sales by Sales Channel (2020-2025) & (M Units)
Table 41. APAC OTC Anti-Infective Products Sales by Region (2020-2025) & (M Units)
Table 42. APAC OTC Anti-Infective Products Sales Market Share by Region (2020-2025)
Table 43. APAC OTC Anti-Infective Products Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC OTC Anti-Infective Products Sales by Type (2020-2025) & (M Units)
Table 45. APAC OTC Anti-Infective Products Sales by Sales Channel (2020-2025) & (M Units)
Table 46. Europe OTC Anti-Infective Products Sales by Country (2020-2025) & (M Units)
Table 47. Europe OTC Anti-Infective Products Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe OTC Anti-Infective Products Sales by Type (2020-2025) & (M Units)
Table 49. Europe OTC Anti-Infective Products Sales by Sales Channel (2020-2025) & (M Units)
Table 50. Middle East & Africa OTC Anti-Infective Products Sales by Country (2020-2025) & (M Units)
Table 51. Middle East & Africa OTC Anti-Infective Products Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa OTC Anti-Infective Products Sales by Type (2020-2025) & (M Units)
Table 53. Middle East & Africa OTC Anti-Infective Products Sales by Sales Channel (2020-2025) & (M Units)
Table 54. Key Market Drivers & Growth Opportunities of OTC Anti-Infective Products
Table 55. Key Market Challenges & Risks of OTC Anti-Infective Products
Table 56. Key Industry Trends of OTC Anti-Infective Products
Table 57. OTC Anti-Infective Products Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. OTC Anti-Infective Products Distributors List
Table 60. OTC Anti-Infective Products Customer List
Table 61. Global OTC Anti-Infective Products Sales Forecast by Region (2026-2031) & (M Units)
Table 62. Global OTC Anti-Infective Products Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas OTC Anti-Infective Products Sales Forecast by Country (2026-2031) & (M Units)
Table 64. Americas OTC Anti-Infective Products Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC OTC Anti-Infective Products Sales Forecast by Region (2026-2031) & (M Units)
Table 66. APAC OTC Anti-Infective Products Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe OTC Anti-Infective Products Sales Forecast by Country (2026-2031) & (M Units)
Table 68. Europe OTC Anti-Infective Products Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa OTC Anti-Infective Products Sales Forecast by Country (2026-2031) & (M Units)
Table 70. Middle East & Africa OTC Anti-Infective Products Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global OTC Anti-Infective Products Sales Forecast by Type (2026-2031) & (M Units)
Table 72. Global OTC Anti-Infective Products Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global OTC Anti-Infective Products Sales Forecast by Sales Channel (2026-2031) & (M Units)
Table 74. Global OTC Anti-Infective Products Revenue Forecast by Sales Channel (2026-2031) & ($ millions)
Table 75. Bayer Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 76. Bayer OTC Anti-Infective Products Product Portfolios and Specifications
Table 77. Bayer OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Bayer Main Business
Table 79. Bayer Latest Developments
Table 80. GSK Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 81. GSK OTC Anti-Infective Products Product Portfolios and Specifications
Table 82. GSK OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. GSK Main Business
Table 84. GSK Latest Developments
Table 85. Teva Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 86. Teva OTC Anti-Infective Products Product Portfolios and Specifications
Table 87. Teva OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Teva Main Business
Table 89. Teva Latest Developments
Table 90. Johnson & Johnson Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 91. Johnson & Johnson OTC Anti-Infective Products Product Portfolios and Specifications
Table 92. Johnson & Johnson OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Johnson & Johnson Main Business
Table 94. Johnson & Johnson Latest Developments
Table 95. NOVARTIS Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 96. NOVARTIS OTC Anti-Infective Products Product Portfolios and Specifications
Table 97. NOVARTIS OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. NOVARTIS Main Business
Table 99. NOVARTIS Latest Developments
Table 100. MYLAN Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 101. MYLAN OTC Anti-Infective Products Product Portfolios and Specifications
Table 102. MYLAN OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. MYLAN Main Business
Table 104. MYLAN Latest Developments
Table 105. Sun Pharma Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 106. Sun Pharma OTC Anti-Infective Products Product Portfolios and Specifications
Table 107. Sun Pharma OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Sun Pharma Main Business
Table 109. Sun Pharma Latest Developments
Table 110. CR SANJIU Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 111. CR SANJIU OTC Anti-Infective Products Product Portfolios and Specifications
Table 112. CR SANJIU OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. CR SANJIU Main Business
Table 114. CR SANJIU Latest Developments
Table 115. Cipla Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 116. Cipla OTC Anti-Infective Products Product Portfolios and Specifications
Table 117. Cipla OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Cipla Main Business
Table 119. Cipla Latest Developments
Table 120. Lingrui Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 121. Lingrui OTC Anti-Infective Products Product Portfolios and Specifications
Table 122. Lingrui OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Lingrui Main Business
Table 124. Lingrui Latest Developments
Table 1. OTC Anti-Infective Products Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. OTC Anti-Infective Products Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Antifungal
Table 4. Major Players of Antibacterial
Table 5. Major Players of Antiviral
Table 6. Major Players of Antiseptics
Table 7. Major Players of Others
Table 8. Global OTC Anti-Infective Products Sales by Type (2020-2025) & (M Units)
Table 9. Global OTC Anti-Infective Products Sales Market Share by Type (2020-2025)
Table 10. Global OTC Anti-Infective Products Revenue by Type (2020-2025) & ($ million)
Table 11. Global OTC Anti-Infective Products Revenue Market Share by Type (2020-2025)
Table 12. Global OTC Anti-Infective Products Sale Price by Type (2020-2025) & (US$/Unit)
Table 13. Global OTC Anti-Infective Products Sale by Sales Channel (2020-2025) & (M Units)
Table 14. Global OTC Anti-Infective Products Sale Market Share by Sales Channel (2020-2025)
Table 15. Global OTC Anti-Infective Products Revenue by Sales Channel (2020-2025) & ($ million)
Table 16. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2020-2025)
Table 17. Global OTC Anti-Infective Products Sale Price by Sales Channel (2020-2025) & (US$/Unit)
Table 18. Global OTC Anti-Infective Products Sales by Company (2020-2025) & (M Units)
Table 19. Global OTC Anti-Infective Products Sales Market Share by Company (2020-2025)
Table 20. Global OTC Anti-Infective Products Revenue by Company (2020-2025) & ($ millions)
Table 21. Global OTC Anti-Infective Products Revenue Market Share by Company (2020-2025)
Table 22. Global OTC Anti-Infective Products Sale Price by Company (2020-2025) & (US$/Unit)
Table 23. Key Manufacturers OTC Anti-Infective Products Producing Area Distribution and Sales Area
Table 24. Players OTC Anti-Infective Products Products Offered
Table 25. OTC Anti-Infective Products Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global OTC Anti-Infective Products Sales by Geographic Region (2020-2025) & (M Units)
Table 29. Global OTC Anti-Infective Products Sales Market Share Geographic Region (2020-2025)
Table 30. Global OTC Anti-Infective Products Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global OTC Anti-Infective Products Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global OTC Anti-Infective Products Sales by Country/Region (2020-2025) & (M Units)
Table 33. Global OTC Anti-Infective Products Sales Market Share by Country/Region (2020-2025)
Table 34. Global OTC Anti-Infective Products Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global OTC Anti-Infective Products Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas OTC Anti-Infective Products Sales by Country (2020-2025) & (M Units)
Table 37. Americas OTC Anti-Infective Products Sales Market Share by Country (2020-2025)
Table 38. Americas OTC Anti-Infective Products Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas OTC Anti-Infective Products Sales by Type (2020-2025) & (M Units)
Table 40. Americas OTC Anti-Infective Products Sales by Sales Channel (2020-2025) & (M Units)
Table 41. APAC OTC Anti-Infective Products Sales by Region (2020-2025) & (M Units)
Table 42. APAC OTC Anti-Infective Products Sales Market Share by Region (2020-2025)
Table 43. APAC OTC Anti-Infective Products Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC OTC Anti-Infective Products Sales by Type (2020-2025) & (M Units)
Table 45. APAC OTC Anti-Infective Products Sales by Sales Channel (2020-2025) & (M Units)
Table 46. Europe OTC Anti-Infective Products Sales by Country (2020-2025) & (M Units)
Table 47. Europe OTC Anti-Infective Products Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe OTC Anti-Infective Products Sales by Type (2020-2025) & (M Units)
Table 49. Europe OTC Anti-Infective Products Sales by Sales Channel (2020-2025) & (M Units)
Table 50. Middle East & Africa OTC Anti-Infective Products Sales by Country (2020-2025) & (M Units)
Table 51. Middle East & Africa OTC Anti-Infective Products Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa OTC Anti-Infective Products Sales by Type (2020-2025) & (M Units)
Table 53. Middle East & Africa OTC Anti-Infective Products Sales by Sales Channel (2020-2025) & (M Units)
Table 54. Key Market Drivers & Growth Opportunities of OTC Anti-Infective Products
Table 55. Key Market Challenges & Risks of OTC Anti-Infective Products
Table 56. Key Industry Trends of OTC Anti-Infective Products
Table 57. OTC Anti-Infective Products Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. OTC Anti-Infective Products Distributors List
Table 60. OTC Anti-Infective Products Customer List
Table 61. Global OTC Anti-Infective Products Sales Forecast by Region (2026-2031) & (M Units)
Table 62. Global OTC Anti-Infective Products Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas OTC Anti-Infective Products Sales Forecast by Country (2026-2031) & (M Units)
Table 64. Americas OTC Anti-Infective Products Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC OTC Anti-Infective Products Sales Forecast by Region (2026-2031) & (M Units)
Table 66. APAC OTC Anti-Infective Products Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe OTC Anti-Infective Products Sales Forecast by Country (2026-2031) & (M Units)
Table 68. Europe OTC Anti-Infective Products Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa OTC Anti-Infective Products Sales Forecast by Country (2026-2031) & (M Units)
Table 70. Middle East & Africa OTC Anti-Infective Products Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global OTC Anti-Infective Products Sales Forecast by Type (2026-2031) & (M Units)
Table 72. Global OTC Anti-Infective Products Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global OTC Anti-Infective Products Sales Forecast by Sales Channel (2026-2031) & (M Units)
Table 74. Global OTC Anti-Infective Products Revenue Forecast by Sales Channel (2026-2031) & ($ millions)
Table 75. Bayer Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 76. Bayer OTC Anti-Infective Products Product Portfolios and Specifications
Table 77. Bayer OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Bayer Main Business
Table 79. Bayer Latest Developments
Table 80. GSK Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 81. GSK OTC Anti-Infective Products Product Portfolios and Specifications
Table 82. GSK OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. GSK Main Business
Table 84. GSK Latest Developments
Table 85. Teva Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 86. Teva OTC Anti-Infective Products Product Portfolios and Specifications
Table 87. Teva OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Teva Main Business
Table 89. Teva Latest Developments
Table 90. Johnson & Johnson Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 91. Johnson & Johnson OTC Anti-Infective Products Product Portfolios and Specifications
Table 92. Johnson & Johnson OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Johnson & Johnson Main Business
Table 94. Johnson & Johnson Latest Developments
Table 95. NOVARTIS Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 96. NOVARTIS OTC Anti-Infective Products Product Portfolios and Specifications
Table 97. NOVARTIS OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. NOVARTIS Main Business
Table 99. NOVARTIS Latest Developments
Table 100. MYLAN Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 101. MYLAN OTC Anti-Infective Products Product Portfolios and Specifications
Table 102. MYLAN OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. MYLAN Main Business
Table 104. MYLAN Latest Developments
Table 105. Sun Pharma Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 106. Sun Pharma OTC Anti-Infective Products Product Portfolios and Specifications
Table 107. Sun Pharma OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Sun Pharma Main Business
Table 109. Sun Pharma Latest Developments
Table 110. CR SANJIU Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 111. CR SANJIU OTC Anti-Infective Products Product Portfolios and Specifications
Table 112. CR SANJIU OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. CR SANJIU Main Business
Table 114. CR SANJIU Latest Developments
Table 115. Cipla Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 116. Cipla OTC Anti-Infective Products Product Portfolios and Specifications
Table 117. Cipla OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Cipla Main Business
Table 119. Cipla Latest Developments
Table 120. Lingrui Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 121. Lingrui OTC Anti-Infective Products Product Portfolios and Specifications
Table 122. Lingrui OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Lingrui Main Business
Table 124. Lingrui Latest Developments
LIST OF FIGURES
Figure 1. Picture of OTC Anti-Infective Products
Figure 2. OTC Anti-Infective Products Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global OTC Anti-Infective Products Sales Growth Rate 2020-2031 (M Units)
Figure 7. Global OTC Anti-Infective Products Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. OTC Anti-Infective Products Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. OTC Anti-Infective Products Sales Market Share by Country/Region (2024)
Figure 10. OTC Anti-Infective Products Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Antifungal
Figure 12. Product Picture of Antibacterial
Figure 13. Product Picture of Antiviral
Figure 14. Product Picture of Antiseptics
Figure 15. Product Picture of Others
Figure 16. Global OTC Anti-Infective Products Sales Market Share by Type in 2025
Figure 17. Global OTC Anti-Infective Products Revenue Market Share by Type (2020-2025)
Figure 18. OTC Anti-Infective Products Consumed in Hospital Pharmacies
Figure 19. Global OTC Anti-Infective Products Market: Hospital Pharmacies (2020-2025) & (M Units)
Figure 20. OTC Anti-Infective Products Consumed in Retail Pharmacies
Figure 21. Global OTC Anti-Infective Products Market: Retail Pharmacies (2020-2025) & (M Units)
Figure 22. OTC Anti-Infective Products Consumed in Online Pharmacies
Figure 23. Global OTC Anti-Infective Products Market: Online Pharmacies (2020-2025) & (M Units)
Figure 24. Global OTC Anti-Infective Products Sale Market Share by Sales Channel (2024)
Figure 25. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel in 2025
Figure 26. OTC Anti-Infective Products Sales by Company in 2025 (M Units)
Figure 27. Global OTC Anti-Infective Products Sales Market Share by Company in 2025
Figure 28. OTC Anti-Infective Products Revenue by Company in 2025 ($ millions)
Figure 29. Global OTC Anti-Infective Products Revenue Market Share by Company in 2025
Figure 30. Global OTC Anti-Infective Products Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global OTC Anti-Infective Products Revenue Market Share by Geographic Region in 2025
Figure 32. Americas OTC Anti-Infective Products Sales 2020-2025 (M Units)
Figure 33. Americas OTC Anti-Infective Products Revenue 2020-2025 ($ millions)
Figure 34. APAC OTC Anti-Infective Products Sales 2020-2025 (M Units)
Figure 35. APAC OTC Anti-Infective Products Revenue 2020-2025 ($ millions)
Figure 36. Europe OTC Anti-Infective Products Sales 2020-2025 (M Units)
Figure 37. Europe OTC Anti-Infective Products Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa OTC Anti-Infective Products Sales 2020-2025 (M Units)
Figure 39. Middle East & Africa OTC Anti-Infective Products Revenue 2020-2025 ($ millions)
Figure 40. Americas OTC Anti-Infective Products Sales Market Share by Country in 2025
Figure 41. Americas OTC Anti-Infective Products Revenue Market Share by Country (2020-2025)
Figure 42. Americas OTC Anti-Infective Products Sales Market Share by Type (2020-2025)
Figure 43. Americas OTC Anti-Infective Products Sales Market Share by Sales Channel (2020-2025)
Figure 44. United States OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC OTC Anti-Infective Products Sales Market Share by Region in 2025
Figure 49. APAC OTC Anti-Infective Products Revenue Market Share by Region (2020-2025)
Figure 50. APAC OTC Anti-Infective Products Sales Market Share by Type (2020-2025)
Figure 51. APAC OTC Anti-Infective Products Sales Market Share by Sales Channel (2020-2025)
Figure 52. China OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 56. India OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 58. ChinaTaiwan OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe OTC Anti-Infective Products Sales Market Share by Country in 2025
Figure 60. Europe OTC Anti-Infective Products Revenue Market Share by Country (2020-2025)
Figure 61. Europe OTC Anti-Infective Products Sales Market Share by Type (2020-2025)
Figure 62. Europe OTC Anti-Infective Products Sales Market Share by Sales Channel (2020-2025)
Figure 63. Germany OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 64. France OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 65. UK OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Sales Channel (2020-2025)
Figure 71. Egypt OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of OTC Anti-Infective Products in 2025
Figure 77. Manufacturing Process Analysis of OTC Anti-Infective Products
Figure 78. Industry Chain Structure of OTC Anti-Infective Products
Figure 79. Channels of Distribution
Figure 80. Global OTC Anti-Infective Products Sales Market Forecast by Region (2026-2031)
Figure 81. Global OTC Anti-Infective Products Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global OTC Anti-Infective Products Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global OTC Anti-Infective Products Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global OTC Anti-Infective Products Sales Market Share Forecast by Sales Channel (2026-2031)
Figure 85. Global OTC Anti-Infective Products Revenue Market Share Forecast by Sales Channel (2026-2031)
Figure 1. Picture of OTC Anti-Infective Products
Figure 2. OTC Anti-Infective Products Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global OTC Anti-Infective Products Sales Growth Rate 2020-2031 (M Units)
Figure 7. Global OTC Anti-Infective Products Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. OTC Anti-Infective Products Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. OTC Anti-Infective Products Sales Market Share by Country/Region (2024)
Figure 10. OTC Anti-Infective Products Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Antifungal
Figure 12. Product Picture of Antibacterial
Figure 13. Product Picture of Antiviral
Figure 14. Product Picture of Antiseptics
Figure 15. Product Picture of Others
Figure 16. Global OTC Anti-Infective Products Sales Market Share by Type in 2025
Figure 17. Global OTC Anti-Infective Products Revenue Market Share by Type (2020-2025)
Figure 18. OTC Anti-Infective Products Consumed in Hospital Pharmacies
Figure 19. Global OTC Anti-Infective Products Market: Hospital Pharmacies (2020-2025) & (M Units)
Figure 20. OTC Anti-Infective Products Consumed in Retail Pharmacies
Figure 21. Global OTC Anti-Infective Products Market: Retail Pharmacies (2020-2025) & (M Units)
Figure 22. OTC Anti-Infective Products Consumed in Online Pharmacies
Figure 23. Global OTC Anti-Infective Products Market: Online Pharmacies (2020-2025) & (M Units)
Figure 24. Global OTC Anti-Infective Products Sale Market Share by Sales Channel (2024)
Figure 25. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel in 2025
Figure 26. OTC Anti-Infective Products Sales by Company in 2025 (M Units)
Figure 27. Global OTC Anti-Infective Products Sales Market Share by Company in 2025
Figure 28. OTC Anti-Infective Products Revenue by Company in 2025 ($ millions)
Figure 29. Global OTC Anti-Infective Products Revenue Market Share by Company in 2025
Figure 30. Global OTC Anti-Infective Products Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global OTC Anti-Infective Products Revenue Market Share by Geographic Region in 2025
Figure 32. Americas OTC Anti-Infective Products Sales 2020-2025 (M Units)
Figure 33. Americas OTC Anti-Infective Products Revenue 2020-2025 ($ millions)
Figure 34. APAC OTC Anti-Infective Products Sales 2020-2025 (M Units)
Figure 35. APAC OTC Anti-Infective Products Revenue 2020-2025 ($ millions)
Figure 36. Europe OTC Anti-Infective Products Sales 2020-2025 (M Units)
Figure 37. Europe OTC Anti-Infective Products Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa OTC Anti-Infective Products Sales 2020-2025 (M Units)
Figure 39. Middle East & Africa OTC Anti-Infective Products Revenue 2020-2025 ($ millions)
Figure 40. Americas OTC Anti-Infective Products Sales Market Share by Country in 2025
Figure 41. Americas OTC Anti-Infective Products Revenue Market Share by Country (2020-2025)
Figure 42. Americas OTC Anti-Infective Products Sales Market Share by Type (2020-2025)
Figure 43. Americas OTC Anti-Infective Products Sales Market Share by Sales Channel (2020-2025)
Figure 44. United States OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC OTC Anti-Infective Products Sales Market Share by Region in 2025
Figure 49. APAC OTC Anti-Infective Products Revenue Market Share by Region (2020-2025)
Figure 50. APAC OTC Anti-Infective Products Sales Market Share by Type (2020-2025)
Figure 51. APAC OTC Anti-Infective Products Sales Market Share by Sales Channel (2020-2025)
Figure 52. China OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 56. India OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 58. ChinaTaiwan OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe OTC Anti-Infective Products Sales Market Share by Country in 2025
Figure 60. Europe OTC Anti-Infective Products Revenue Market Share by Country (2020-2025)
Figure 61. Europe OTC Anti-Infective Products Sales Market Share by Type (2020-2025)
Figure 62. Europe OTC Anti-Infective Products Sales Market Share by Sales Channel (2020-2025)
Figure 63. Germany OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 64. France OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 65. UK OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Sales Channel (2020-2025)
Figure 71. Egypt OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries OTC Anti-Infective Products Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of OTC Anti-Infective Products in 2025
Figure 77. Manufacturing Process Analysis of OTC Anti-Infective Products
Figure 78. Industry Chain Structure of OTC Anti-Infective Products
Figure 79. Channels of Distribution
Figure 80. Global OTC Anti-Infective Products Sales Market Forecast by Region (2026-2031)
Figure 81. Global OTC Anti-Infective Products Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global OTC Anti-Infective Products Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global OTC Anti-Infective Products Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global OTC Anti-Infective Products Sales Market Share Forecast by Sales Channel (2026-2031)
Figure 85. Global OTC Anti-Infective Products Revenue Market Share Forecast by Sales Channel (2026-2031)
More Publications
Global Clinical Data Analytics in Healthcare Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
115 pages
Global Divalproex Sodium Market Growth 2025-2031
US$ 3,660.00
March 2025
87 pages
Global Connected Health Wellness Devices Market Growth 2023-2029
US$ 3,660.00
February 2023
115 pages
Global Transforming Growth Factor Beta 1 Market Growth 2025-2031
US$ 3,660.00
January 2025
89 pages
